rhinovirus (strain 16)
Vaccineexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2013 (NCT02388997)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Human rhinovirus 2Immunity, active
Human rhinovirus 2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhinovirus (strain 16)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02660489 | Phase 2 | Oct 1, 2015 | Atopix Therapeutics, Ltd., Medical Research Council, University of London |
| NCT02111772 | N/A | Sep 1, 2013 | National Institutes of Health (NIH), University of Virginia |
| NCT02388997 | Phase 2 | Feb 1, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), University of Virginia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Virginia | Academic/Hospital | 2 | 2 | 2 | 2013 |
| Atopix Therapeutics, Ltd. | For profit | 1 | 0 | 1 | 2015 |
| Medical Research Council | Government | 1 | 0 | 1 | 2015 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2013 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2013 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2015 |
6 organizations
Page 1 / 1